Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
Company profile
Ticker
OTIC
Exchange
Website
CEO
David Weber
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
OTIC stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
4 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
EFFECT
Notice of effectiveness
3 Apr 23
POS AM
Prospectus update (post-effective amendment)
30 Mar 23
POS AM
Prospectus update (post-effective amendment)
30 Mar 23
POS AM
Prospectus update (post-effective amendment)
30 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 23
Transcripts
OTIC
Earnings call transcript
2022 Q2
26 Jul 22
OTIC
Earnings call transcript
2022 Q1
10 May 22
OTIC
Earnings call transcript
2021 Q4
1 Mar 22
OTIC
Earnings call transcript
2021 Q3
11 Nov 21
OTIC
Earnings call transcript
2021 Q2
5 Aug 21
OTIC
Earnings call transcript
2021 Q1
12 May 21
OTIC
Earnings call transcript
2020 Q4
12 Feb 21
OTIC
Earnings call transcript
2020 Q3
4 Nov 20
OTIC
Earnings call transcript
2020 Q3
4 Nov 20
OTIC
Earnings call transcript
2020 Q2
5 Aug 20
Latest ownership filings
3
H MICHAEL HOGAN III
24 Feb 23
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 23
SC 13G/A
SUVRETTA CAPITAL MANAGEMENT, LLC
13 Feb 23
SC 13G/A
BAKER BROS. ADVISORS LP
10 Feb 23
SC 13G/A
ADAGE CAPITAL PARTNERS GP, L.L.C.
9 Feb 23
4
David Allen Weber
30 Dec 22
4
Paul E Cayer
30 Dec 22
SC 13D
Elk Capital Markets UK LTD
27 Dec 22
4
VICKIE L CAPPS
29 Nov 22
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Nov 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.85 mm | 40.85 mm | 40.85 mm | 40.85 mm | 40.85 mm | 40.85 mm |
Cash burn (monthly) | 4.33 mm | 3.47 mm | 3.95 mm | 4.24 mm | 4.34 mm | 3.90 mm |
Cash used (since last report) | 81.94 mm | 65.69 mm | 74.62 mm | 80.23 mm | 82.00 mm | 73.69 mm |
Cash remaining | -41.09 mm | -24.85 mm | -33.78 mm | -39.38 mm | -41.15 mm | -32.84 mm |
Runway (months of cash) | -9.5 | -7.2 | -8.6 | -9.3 | -9.5 | -8.4 |
Institutional ownership, Q4 2022
12.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 8 |
Opened positions | 3 |
Closed positions | 32 |
Increased positions | 1 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 2.63 mm |
Total shares | 8.84 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Elk Capital Markets UK | 4.75 mm | $581.00 k |
Baker Bros. Advisors | 3.45 mm | $339.00 k |
Acadian Asset Management | 617.18 k | $53.00 k |
National Asset Management | 10.00 k | $871.00 k |
Newbridge Financial Services | 8.00 k | $697.00 k |
Simplex Trading | 1.22 k | $0.00 |
Steward Partners Investment Advisory | 1.00 k | $87.00 k |
Tower Research Capital | 90.00 | $0.00 |
Adage Capital Partners GP, L.L.C. | 0.00 | $0.00 |
Ra Capital Management | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 22 | Weber David Allen | Common Stock | Payment of exercise | Dispose F | No | No | 0.088 | 91,636 | 8.06 k | 285,863 |
28 Dec 22 | Paul E Cayer | Common Stock | Payment of exercise | Dispose F | No | No | 0.087 | 40,054 | 3.48 k | 183,733 |
28 Nov 22 | Capps Vickie L | Common Stock | Sell | Dispose S | No | No | 0.1028 | 42,242 | 4.34 k | 3,400 |